Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Sees Large Increase in Short Interest

Bullfrog AI Holdings, Inc. (NASDAQ:BFRGGet Free Report) saw a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 756,800 shares, an increase of 60.2% from the January 31st total of 472,300 shares. Approximately 12.2% of the company’s shares are sold short. Based on an average trading volume of 809,000 shares, the days-to-cover ratio is presently 0.9 days.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. Two Sigma Securities LLC purchased a new position in shares of Bullfrog AI during the fourth quarter valued at $41,000. Raymond James Financial Inc. purchased a new position in Bullfrog AI during the 4th quarter valued at about $30,000. Finally, Geode Capital Management LLC raised its holdings in shares of Bullfrog AI by 31.0% in the 4th quarter. Geode Capital Management LLC now owns 47,093 shares of the company’s stock valued at $94,000 after purchasing an additional 11,140 shares in the last quarter. 0.96% of the stock is currently owned by hedge funds and other institutional investors.

Bullfrog AI Stock Performance

Bullfrog AI stock remained flat at $1.89 during trading hours on Tuesday. 171,834 shares of the company’s stock traded hands, compared to its average volume of 324,254. The business’s 50-day simple moving average is $2.51 and its 200-day simple moving average is $2.46. Bullfrog AI has a 12 month low of $1.43 and a 12 month high of $4.84. The company has a market cap of $16.47 million, a price-to-earnings ratio of -2.22 and a beta of 0.18.

About Bullfrog AI

(Get Free Report)

Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.

See Also

Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.